Correlation Between FMEGR and Spyre Therapeutics
Specify exactly 2 symbols:
By analyzing existing cross correlation between FMEGR 3 01 DEC 31 and Spyre Therapeutics, you can compare the effects of market volatilities on FMEGR and Spyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in FMEGR with a short position of Spyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of FMEGR and Spyre Therapeutics.
Diversification Opportunities for FMEGR and Spyre Therapeutics
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between FMEGR and Spyre is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding FMEGR 3 01 DEC 31 and Spyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spyre Therapeutics and FMEGR is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on FMEGR 3 01 DEC 31 are associated (or correlated) with Spyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spyre Therapeutics has no effect on the direction of FMEGR i.e., FMEGR and Spyre Therapeutics go up and down completely randomly.
Pair Corralation between FMEGR and Spyre Therapeutics
Assuming the 90 days trading horizon FMEGR 3 01 DEC 31 is expected to generate 0.32 times more return on investment than Spyre Therapeutics. However, FMEGR 3 01 DEC 31 is 3.1 times less risky than Spyre Therapeutics. It trades about -0.04 of its potential returns per unit of risk. Spyre Therapeutics is currently generating about -0.27 per unit of risk. If you would invest 8,373 in FMEGR 3 01 DEC 31 on September 4, 2024 and sell it today you would lose (45.00) from holding FMEGR 3 01 DEC 31 or give up 0.54% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 42.86% |
| Values | Daily Returns |
FMEGR 3 01 DEC 31 vs. Spyre Therapeutics
Performance |
| Timeline |
| FMEGR 3 01 |
| Spyre Therapeutics |
FMEGR and Spyre Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with FMEGR and Spyre Therapeutics
The main advantage of trading using opposite FMEGR and Spyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if FMEGR position performs unexpectedly, Spyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spyre Therapeutics will offset losses from the drop in Spyre Therapeutics' long position.| FMEGR vs. Spyre Therapeutics | FMEGR vs. Playtika Holding Corp | FMEGR vs. Inhibrx | FMEGR vs. Northstar Clean Technologies |
| Spyre Therapeutics vs. RBC Bearings Incorporated | Spyre Therapeutics vs. Newpark Resources | Spyre Therapeutics vs. The Wendys Co | Spyre Therapeutics vs. Park Hotels Resorts |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |